Key result
Early Parkinson's disease was associated with reduced pilomotor function compared to healthy controls, measured by spatial axon-reflex spread (78 vs 175 mm2; p=0.01).
Why the study?
The study was conducted to longitudinally characterize autonomic pilomotor and sudomotor skin function in early Parkinson's disease.
Does autonomic skin function differ between patients with early Parkinson's disease and healthy individuals over 2 years?
Observational (n=38)
Yes
Does autonomic skin function differ between patients with early Parkinson's disease and healthy individuals over 2 years?
Impairment of adrenergic sympathetic pilomotor function and sympathetic skin response is present in early Parkinson's disease and worsens over time, suggesting a sympathetic pathophysiology that could serve as a biomarker.
Background and purpose We characterized autonomic pilomotor and sudomotor skin function in early Parkinson's disease (PD) longitudinally. Methods We enrolled PD patients (Hoehn and Yahr 1–2) and healthy controls from movement disorder centers in Germany, Hungary, and the United States. We evaluated axon‐reflex responses in adrenergic sympathetic pilomotor nerves and in cholinergic sudomotor nerves and assessed sympathetic skin response (SSR), predominantly parasympathetic neurocardiac function via heart rate variability, and disease‐related symptoms at baseline, after 2 weeks, and after 1 and 2 years. Clinicaltrials.gov : NCT03043768. Results We included 38 participants: 26 PD (60% females, aged 62.4 ± 7.4 years, mean ± SD) and 12 controls (75% females, aged 59.5 ± 5.8 years). Pilomotor function was reduced in PD compared to controls at baseline when quantified via spatial axon‐reflex spread (78 [43–143], median [interquartile range] mm 2 vs. 175 [68–200] mm 2 , p = 0.01) or erect hair follicle count in the axon‐reflex region (8 [6–10] vs. 11 [6–16], p = 0.008) and showed reliability absent any changes from baseline to Week 2 ( p = not significant [ns]). Between‐group differences increased over the course of 2 years ( p < 0.05), although no decline was observed within groups ( p = ns). Pilomotor impairment in PD correlated with motor symptoms (rho = −0.59, p = 0.017) and was not lateralized ( p = ns). Sudomotor axon‐reflex and neurocardiac function did not differ between groups ( p = ns), but SSR was reduced in PD ( p = 0.0001). Conclusions Impairment of adrenergic sympathetic pilomotor function and SSR in evolving PD is not paralleled by changes to cholinergic sudomotor function and parasympathetic neurocardiac function, suggesting a sympathetic pathophysiology. A pilomotor axon‐reflex test might be useful to monitor PD‐related pathology.
No takes yet. Share an insight, caveat, or question.
Siepmann et al. (2023) conducted an observational in Parkinson's disease (n=38). Parkinson's disease vs. Healthy controls was evaluated on Spatial axon-reflex spread (p=0.01). Early Parkinson's disease was associated with reduced pilomotor function compared to healthy controls, measured by spatial axon-reflex spread (78 vs 175 mm2; p=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: